Onglyza (on-GLY-zah), the second "gliptin" for type 2 diabetes
September 2009
Reps will be promoting Onglyza (on-GLY-zah), the second "gliptin" for type 2 diabetes.
Think of it as similar to Januvia.
Onglyza (saxagliptin) and Januvia (sitagliptin) are incretin enhancers. They prolong the action of endogenous incretin hormones by blocking their breakdown by the enzyme, dipeptidyl peptidase-4 (DPP-4). This leads to more insulin release after eating.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote